Vall d'Hebron Institute of Oncology

Barcelona 08035

3 studies enrolling now · 18 studies all time

What they study most

Acute T Cell Leukemia Lymphoma, Adult Disease, Adult Solid Tumor, Advanced Malignant Neoplasm, Advanced Solid Tumor, Advanced Solid Tumors, Bone Cancer, Bone Metastases, Bone Neoplasm, Breast Neoplasms, Cancer, Cervical Cancer

Studies at this site

• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now
• A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer — Recruiting now
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy — Recruiting now
• [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake — Completed
• Phase III Study of AK112 for NSCLC Patients — Running, not enrolling
• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
• A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors — Completed
• A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy — Running, not enrolling
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies — Running, not enrolling
• Study to Assess AFM24 in Advanced Solid Cancers — Stopped early
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression — Completed
• Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies — Completed
• A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma — Completed
• A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms — Completed
• SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides — Stopped early
• First-in-Human Study of KO-947 in Non-Hematological Malignancies — Stopped early